New Genomic Techniques: Trilogue agreement reached

10 March 2026

New Genomic Techniques: Trilogue agreement reached

By Jenny Brunton, Senior European Policy Advisor

In mid-December 2025, the Council and the European Parliament reached a provisional agreement to establish a legal framework for new genomic techniques (NGTs). Subject to formal endorsement, the agreement paves the way for the development of the technology in the EU, which in turn will be important for the future EU/UK SPS agreement.

NGTs in the EU

The provisional EU agreement maintains the principle that NGT-1 plants are equivalent to conventional plants, in line with the Commission proposal. National authorities must verify that NGT plants belong to category 1, but their offspring do not need to be subsequently verified. Importantly, NGT-1 plants and products will not need to be labelled with the exception of seeds and other plant reproductive material of NGT-1 plants. The legislators believe this would not entail a disproportionate burden for plant breeders and would allow operators to ensure an NGT-free chain, if they wish to do so.

Furthermore, the agreement includes a list of intended traits that must be excluded from the NGT-1 category, including tolerance to herbicides and ‘production of a known insecticidal substance’ will be on the exclusion list and cannot be one of the intended traits for category 1 NGT plants. This change to the Commission’s original proposal will mean that such plants are classed as NGT-2 and therefore remain subject to GMO authorisation, traceability and monitoring.

Protection of intellectual property (IP)

Alongside labelling, protection of IP has been one the thorniest issues in the negation of this file. The agreement reached attempts to strike a balance between the concerns of plant breeders and farmers. Patent rules are governed by the EU's Biotech Directive, and when applying to register a category 1 NGT plant or product, companies or breeders must submit information on all existing or pending patents. The patenting information must be included in a publicly available database. Furthermore, on a voluntary basis, companies or breeders can also provide information on the patent holder's intention to licence the use of a patented NGT 1 plant or product, under equitable conditions.

The Council and the Parliament agreed on the creation of a patenting expert group, focusing on the effect of patents on NGT plants, composed of experts from all member states, the European Patent Office and the Community Plant Variety Office. One year after the entry into force of the regulation, the Commission will publish a study on the impact of patenting on innovation, on the availability of seeds to farmers and on the competitiveness of the EU plant breeding sector. The Commission will then indicate what follow-up measures are needed or publish a legislative proposal to address any issues found in the study.

Next steps:

The regulation must now be formally adopted by both the Council and the European Parliament, likely in the April Plenary. It is expected to be published in the Official Journal in 2026 and to take effect no later than two years later. Its implementation will be supported by a monitoring programme assessing economic, environmental and social impacts, including sustainability and safety considerations.

Why should GE and GMO be regulated in different ways?

GE is done by a group of technologies that make the changes within the organism's own DNA by moving, adding or deleting precise pieces of genetic material. Scientists argue that such changes are what happens in conventional breeding and can also come from induced mutations, as seen in the malting barley variety Golden Promise. In contrast to this, GM technologies involve inserting new DNA into an organism’s genome to introduce desired characteristics into plants or animals.

Background: 

On 5 July 2023, the European Commission adopted a proposal for a new Regulation on plants produced by certain new genomic techniques (NGTs) which include advanced methods of gene editing, such as CRISPR-Cas9. These techniques hold promise for advancing agriculture, improving food security, and addressing environmental challenges. The EU's proposal aims to update existing biotechnology regulations to provide a more streamlined framework for their application, while ensuring safety and transparency.

The proposal is accompanied by an impact assessment, supported by an external study, JRC case studies on several applications of NGTs and the scientific work of EFSA in the area of new genomic techniques.

Organic: NGT plants will be prohibited in organic production. For NGT Cat-2 plants subject to authorisation, the legislative proposal maintains the traceability and labelling requirements of the GMO legislation. Today, GMOs are banned in organic production by the EU Organic Production Regulation. In addition, the proposal makes the adoption of coexistence measures at national level mandatory. Member States must adopt measures so that different types of cultivation can exist side by side, e.g., distances between the fields.

To exclude NGT plants from organic production, even those that have been verified to be comparable to conventional plants, organic and GM-free farmers can consult a public register of all NGT products and seed labelling in common catalogues of varieties.

What does this mean for the UK farmers?

Under the EU-UK TCA, Northern Ireland continues to follow EU regulations on plant health and safety, including the use of NGTs.

Under the EU-UK SPS agreement which is currently being negotiated, we understand that there is commitment to align on these new technologies, likely with EU legislation superseding the PB England legislation and the EU regulatory regime applying across the whole of the UK.

Feature

EU NGT Regulation

England Precision Breeding Act 2023

Legal instrument

EU Regulation (directly applicable across 27 Member States)

National Act applying only in England

Current status

Political agreement reached; formal adoption pending

In force; plant regulations operational

Organisms covered

Plants only (initially)

Plants and vertebrate animals in force (secondary legislation for animals not presented))

Key concept

“New Genomic Techniques (NGTs)”

“Precision-bred organisms (PBOs)”

Core test

Whether genetic change could occur naturally or via conventional breeding

Same core principle: changes that could arise naturally or by traditional breeding

Categorisation

Two tiers: NGT-1 (lighter regime) and NGT-2 (full GMO regime)

No formal tiers; binary decision (precision-bred or GMO)

GMO treatment

NGT-1 treated like conventional plants; NGT-2 remain GMOs

Precision-bred organisms are not GMOs

Risk assessment

NGT-1: verification only NGT-2: full GMO risk assessment

Simplified, proportionate assessment for PBOs

Food labelling

NGT-2: mandatory GMO-style labelling NGT-1: generally not labelled at food level

No mandatory labelling of precision-bred food

Seed labelling

Required for NGT-1 seeds

No dedicated seed labelling regime

Traceability

Public databases; formal traceability for NGT-2

Public register of approved PBOs

Member State flexibility

States may opt out of cultivating NGT-2 plants

No internal opt-out (England only framework)

Patent transparency

Disclosure of patent status required

No special patent disclosure requirement

Regulatory philosophy

Balance innovation with precautionary oversight

Innovation-first, science-based proportionality


Ask us a question about this page

Once you have submitted your query someone from the team will contact you. If needed, your query will then be passed to the appropriate NFU policy team.

By completing the form with your details on this page, you are agreeing to have this information sent to the British Agriculture Bureau for the purposes of contacting you regarding your enquiry. Please take time to read the BAB and NFU’s Privacy Policy if you require further information.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.